首页|TBK1:a new target for overcoming cancer immunotherapy resistance

TBK1:a new target for overcoming cancer immunotherapy resistance

扫码查看
原文链接
  • 万方数据
  • 维普

Jizhong Guan、Long Zhang、Fangfang Zhou

展开 >

Institutes of Biology and Medical Science,Soochow University,Suzhou 215123,China

MOE Laboratory of Biosystems Homeostasis and Protection and Innovation Center for Cell Signaling Network,Life Sciences Institute,Zhejiang University,Hangzhou 310058,China

National Key Research and Development Program of ChinaNational Key Research and Development Program of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaZhejiang Natural Science FundGusu Innovation Leading Talent Program

2021YFA11010002022YFA11052008204100932125016U20A2039331925013LD19C070001ZXL2022505

2024

10.1007/s11427-023-2395-y

中国科学:生命科学(英文版)
中国科学院

中国科学:生命科学(英文版)

CSTPCD
影响因子：0.806
ISSN：1674-7305
年,卷(期)：2024.67(1)
  • 5